A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance | NEJM
IJMS | Free Full-Text | Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma | HTML
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Renal Manifestations of Plasma Cell Disorders - American Journal of Kidney Diseases
Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study - The Lancet Haematology
Multiple Myeloma: Diagnosis and Treatment | AAFP
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS) | Blood Cancer Journal
Monoclonal gammopathy of renal significance: Early diagnosis is key - ScienceDirect
Neuropathy associated with IgA monoclonal Gammopathy. A harbinger of AL amyloidosis - Journal of the Neurological Sciences
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS) | Blood Cancer Journal
IgM-MGUS and associated membranoproliferative glomerulonephritis during IVIG administration | SpringerLink
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to management - Maciocia - 2017 - Hematological Oncology - Wiley Online Library
Monoclonal Gammopathy–Associated Peripheral Neuropathy: Diagnosis and Management - Mayo Clinic Proceedings
Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance | NEJM
Prevalence of Monoclonal Gammopathy of Undetermined Significance | NEJM
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement | Blood Cancer Journal
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
MGUS Predicts Worse Prognosis in Patients with Coronary Artery Disease | SpringerLink
Monoclonal gammopathy of undetermined significance - Wikipedia
Contributions of the Bone Microenvironment to Monoclonal Gammopathy of Undetermined Significance Pathogenesis | SpringerLink
Rheumatologic diseases impact the risk of progression of MGUS to overt multiple myeloma - ScienceDirect
Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All | HTML
What is the significance of monoclonal gammopathy of undetermined significance? | RCP Journals
